tiprankstipranks
Trending News
More News >
TruBridge (TBRG)
NASDAQ:TBRG

TruBridge (TBRG) AI Stock Analysis

Compare
220 Followers

Top Page

TBRG

TruBridge

(NASDAQ:TBRG)

Select Model
Select Model
Select Model
Neutral 57 (OpenAI - 5.2)
Rating:57Neutral
Price Target:
$22.50
▲(3.59% Upside)
The score is driven primarily by solid financial momentum in revenue and cash flow and constructive margin guidance, but is held back by weak profitability (negative net margin/ROE), a very high P/E valuation, and only neutral-to-soft technical momentum.
Positive Factors
Robust revenue growth and cash generation
TruBridge's TTM revenue growth (65.5%) and FCF growth (43.05%) show durable top-line expansion with improving cash conversion. Strong operating cash flow relative to net income enhances reinvestment, supports deleveraging and funds platform investments over the next 2–6 months.
Enhanced liquidity and financial flexibility
An enlarged, extended credit facility plus a very low reported debt-to-equity position provides the company durable financial flexibility. This supports working capital, potential tuck-in M&A and execution of cost rationalization without immediate refinancing pressure through 2030.
Strategic partnership expanding platform capabilities
The RevSpring tie-up materially strengthens TruBridge's payment and patient engagement stack, increasing platform stickiness for rural/community providers. Deeper integrated payment optimization is a structural capability that can boost recurring revenue and client retention over the medium term.
Negative Factors
Persistent negative profitability metrics
Despite healthy gross margins and revenue growth, negative net margin and ROE indicate the company still struggles to convert revenue into shareholder returns. This structural profitability gap can constrain reinvestment, limit free cash flow available for shareholders, and delay long-term value creation.
Weak bookings and elongated sales cycles
Material booking declines and management notes of hospital decision delays signal persistent sales-cycle friction. For a services-SaaS hybrid, slower contracting reduces revenue visibility and delays ARR/collection ramps, making growth lumpy and execution riskier over the coming quarters.
Revenue exposure to collections and payer dynamics
A material portion of revenue tied to percent-of-collections and patient payments makes top-line and margins sensitive to payer rules, patient affordability and client billing effectiveness. Those external factors create structural volatility in revenue conversion and margin sustainability.

TruBridge (TBRG) vs. SPDR S&P 500 ETF (SPY)

TruBridge Business Overview & Revenue Model

Company DescriptionTruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence. The company provides acute care solutions and related services for community hospitals, and physician clinics; and patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. In addition, it offers patient liability estimates eligibility verification, claim scrubbing and submission, remittance management, denial/audit management, and contract management; and offers RCM services, such as accounts receivable management, private pay service, medical coding, revenue cycle consulting, and other additional insurance and patient billing services. Further, it offers consulting and business management services; managed IT services; encoder solutions; patient management; financial accounting; clinical; patient care; and enterprise applications. Additionally, it offers TruBridge HER platform, including total system support, national client conference, continuing education, software releases, hardware replacement, cloud electronic health record, forms and supplies, and public cloud infrastructure services; post-acute care software systems, and support and maintenance services; and InstantPHR, an interactive portal and CHBase which funnels data from multiple sources into one platform. The company was formerly known as Computer Programs and Systems, Inc. and changed its name to TruBridge, Inc. in March 2024. TruBridge, Inc. was founded in 1979 and is headquartered in Mobile, Alabama.
How the Company Makes MoneyTruBridge generates revenue primarily through its comprehensive suite of revenue cycle management services, which include billing, coding, collections, and financial reporting for healthcare providers. The company earns money by charging clients a percentage of the collections made from their patient accounts, often structured as a fee-for-service model. Additionally, TruBridge offers software solutions on a subscription basis, allowing healthcare organizations to utilize its technology for managing their operations more effectively. Key revenue streams also include consulting services aimed at optimizing financial performance and compliance. The company might form strategic partnerships with healthcare organizations and technology providers, enhancing its service offerings and expanding its client base, which contributes significantly to its overall earnings.

TruBridge Earnings Call Summary

Earnings Call Date:Nov 06, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 17, 2026
Earnings Call Sentiment Neutral
The earnings call presented a mixed sentiment with significant achievements in financial metrics, cost optimization, and cash flow improvements. However, challenges such as underwhelming bookings and flat Financial Health revenue tempered the overall positive outlook. The company remains optimistic about future growth and margin expansion.
Q3-2025 Updates
Positive Updates
Improved Financial Metrics
Adjusted EBITDA margins expected to expand approximately 600 basis points from 2023 to year-end. Year-to-date, free cash flow improved by $20 million, and debt reduced by $35 million, reducing net leverage by more than 2 turns.
Successful Cost Optimization
Cost optimization initiatives resulted in adjusted EBITDA margin of 18.9% for Q3 2025, marking a 155 basis point improvement compared to the previous year.
Cash Flow and Leverage Improvements
Cash balance increased from $3.8 million at the end of 2023 to approximately $20 million. Free cash flow was $15 million year-to-date in 2025 compared to a cash outflow of $5 million in 2023.
Revenue Growth in Patient Care
Patient Care revenue grew 5.3% year-over-year, driven by SaaS growth and nonrecurring revenues. Excluding Centriq, growth in Patient Care revenue would have been 8.9%.
Positive Outlook for Future
Anticipated 200 basis points of EBITDA margin expansion in 2026 due to ongoing cost optimizations and global workforce transitions.
Negative Updates
Underwhelming Bookings
Bookings came in at $15.5 million, down from $25.6 million sequentially and $21 million year-over-year. The bookings were 20% off internal expectations.
Challenges in Financial Health Revenue
Financial Health revenue was flat year-over-year due to slower performance in some products despite growth in CBO and Encoder revenue.
Delayed Decision-Making in Sales
Hospital decision-making delays led to underperformance in Q3 bookings, attributed to budget cycles and regulatory uncertainties.
Company Guidance
During the TruBridge Third Quarter 2025 Earnings Call, the company provided guidance indicating an expectation of revenue between $86 million to $89 million for the fourth quarter of 2025, with adjusted EBITDA ranging from $16.5 million to $19.5 million. For the full year 2025, the revenue is projected to be between $345 million and $348 million, with adjusted EBITDA expected to range from $65 million to $68 million. This guidance reflects an anticipated adjusted EBITDA margin expansion of approximately 260 basis points compared to the previous year, driven by cost management and ROI-driven cost rationalization. Furthermore, the company foresees a further adjusted EBITDA margin expansion of around 200 basis points in 2026, attributed to continued cost optimization and global offshore transitions, aiming for a margin of 20% by the end of 2025.

TruBridge Financial Statement Overview

Summary
TruBridge exhibits strong revenue growth and improved cash flow generation, positioning it well for future expansion. However, profitability remains a concern with negative net margins and return on equity. The company's balance sheet shows reduced leverage, enhancing financial stability. Continued focus on improving profitability and operational efficiency will be crucial for sustaining growth.
Income Statement
TruBridge has shown a strong revenue growth rate of 65.5% in the TTM, indicating robust top-line expansion. However, the net profit margin remains negative at -1.59%, reflecting challenges in converting revenue growth into profitability. The gross profit margin is healthy at 57.67%, suggesting efficient cost management. EBIT and EBITDA margins are moderate at 5.55% and 7.83%, respectively, indicating room for improvement in operational efficiency.
Balance Sheet
The company's debt-to-equity ratio has significantly improved to 0.025 in the TTM, indicating reduced leverage and a stronger balance sheet. However, the return on equity is negative at -4.37%, highlighting profitability challenges. The equity ratio stands at 45.16%, suggesting a stable capital structure with a reasonable proportion of equity financing.
Cash Flow
TruBridge has achieved a substantial free cash flow growth rate of 43.05% in the TTM, demonstrating strong cash generation capabilities. The operating cash flow to net income ratio is high at 192.08, indicating efficient cash conversion. However, the free cash flow to net income ratio is relatively low at 0.21, suggesting potential reinvestment or debt repayment needs.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue349.88M342.65M339.44M326.65M280.63M264.49M
Gross Profit185.99M174.12M163.57M160.11M144.85M136.25M
EBITDA53.72M34.94M-15.39M47.73M43.11M35.56M
Net Income5.58M-20.44M-45.79M15.87M18.43M14.25M
Balance Sheet
Total Assets399.41K394.43M431.78M430.96M383.35M326.27M
Cash, Cash Equivalents and Short-Term Investments19.92K12.32M3.85M6.95M11.43M12.67M
Total Debt4.57K174.81M203.29M147.24M106.46M83.43M
Total Liabilities219.05K225.74M247.80M199.25M160.78M126.27M
Stockholders Equity180.36K168.69M183.97M231.71M222.57M200.00M
Cash Flow
Free Cash Flow29.43M13.04M-22.35M13.01M37.46M42.48M
Operating Cash Flow38.40M32.13M1.06M32.38M47.74M49.14M
Investing Cash Flow-12.63M4.12M-60.11M-62.73M-69.92M-6.66M
Financing Cash Flow-14.44M-27.74M55.95M25.88M20.93M-37.16M

TruBridge Technical Analysis

Technical Analysis Sentiment
Positive
Last Price21.72
Price Trends
50DMA
21.40
Positive
100DMA
20.80
Positive
200DMA
22.28
Positive
Market Momentum
MACD
0.03
Positive
RSI
57.55
Neutral
STOCH
67.10
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TBRG, the sentiment is Positive. The current price of 21.72 is below the 20-day moving average (MA) of 22.12, above the 50-day MA of 21.40, and below the 200-day MA of 22.28, indicating a bullish trend. The MACD of 0.03 indicates Positive momentum. The RSI at 57.55 is Neutral, neither overbought nor oversold. The STOCH value of 67.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TBRG.

TruBridge Risk Analysis

TruBridge disclosed 44 risk factors in its most recent earnings report. TruBridge reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

TruBridge Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
$268.60M16.4710.88%9.67%1.47%11.33%
61
Neutral
$258.17M-5,138.460.03%24.19%
60
Neutral
$382.58M-5.64-42.13%13.09%-745.95%
59
Neutral
$428.23M27.6566.01%2.52%-3.50%-37.46%
57
Neutral
$326.00M121.851.57%3.75%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
50
Neutral
$176.83M-1.55-31.33%4.64%-17.17%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TBRG
TruBridge
22.70
1.30
6.07%
SLP
Simulations Plus
18.05
-10.20
-36.11%
SPOK
Spok Holdings
13.18
-1.16
-8.09%
OPRX
OptimizeRx
13.36
8.00
149.25%
NRC
National Research
19.49
3.25
20.01%
HCAT
Health Catalyst
2.45
-4.44
-64.44%

TruBridge Corporate Events

Business Operations and StrategyExecutive/Board Changes
TruBridge enters cooperation pact and refreshes board leadership
Positive
Jan 8, 2026

On January 7, 2026, TruBridge entered into a cooperation agreement with its largest shareholder, Pinetree Capital and L6 Holdings, under which the company will expand its board to appoint Pinetree president Damien Leonard as an independent director effective January 12, 2026, with a seat on the compensation committee, and implement a phased board refresh that will see several long-serving directors, including long-time member David Dye, not stand for re-election at the 2026 and 2027 annual meetings. The agreement, which caps the board at seven members after the 2026 annual meeting and includes standstill, voting and non-disparagement commitments from Pinetree, tightens alignment between TruBridge and its largest shareholder, signaling a governance reset aimed at bolstering operational effectiveness, capital allocation discipline and the company’s longer-term growth strategy for shareholders, while Leonard has also indicated he will waive his director fees.

The most recent analyst rating on (TBRG) stock is a Hold with a $24.50 price target. To see the full list of analyst forecasts on TruBridge stock, see the TBRG Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
TruBridge Enhances Credit Facility for Growth
Positive
Dec 1, 2025

On November 25, 2025, TruBridge entered into an Amended and Restated Credit Agreement, increasing its revolving credit facility to $180 million and its term loan facility to $70 million. The agreement, which extends the maturity date to November 2030, enhances TruBridge’s financial flexibility and positions the company for future growth, as stated by CFO Vinay Bassi. This move reflects TruBridge’s disciplined capital allocation strategy aimed at delivering higher value for stakeholders.

The most recent analyst rating on (TBRG) stock is a Hold with a $23.50 price target. To see the full list of analyst forecasts on TruBridge stock, see the TBRG Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 09, 2026